SONOMA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2017-12-31 was 0.00 shares.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-12-31 was 0.00 shares.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-09-30 was 0.00 shares.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-06-30 was 0.00 shares.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 0.00 shares.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was 0.00 shares.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2014 was 0.00 shares.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2013 was -10.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2017-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-14 | |
| 2016-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-17 | 0.00 shares derived: sum of 4 quarters · filed 2017-02-17 |
| 2016-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-15 | 0.00 shares derived: sum of 4 quarters · filed 2016-11-15 |
| 2016-06-30 | 0.00 shares 10-Q · filed 2016-08-09 | 0.00 shares derived: sum of 4 quarters · filed 2016-08-09 |
| 2016-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-21 | 0.00 shares 10-K · filed 2016-06-21 |
| 2015-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-16 | |
| 2015-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-10 | |
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-07 | |
| 2015-03-31 | 0.00 shares 10-K · filed 2015-06-16 | |
| 2014-06-30 | 0.00 shares 10-Q · filed 2014-08-12 | |
| 2014-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-30 | 0.00 shares 10-K · filed 2014-06-30 |
| 2013-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | |
| 2013-03-31 | -9.96K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-30 | -10.00K shares 10-K · filed 2014-06-30 |
| 2012-03-31 | -19.00 shares 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |